Literature DB >> 8828283

Spectrographic differences between tracheal-esophageal and esophageal voice.

G Bertino1, A Bellomo, C Miani, F Ferrero, A Staffieri.   

Abstract

In order to evaluate the results of voice and speech rehabilitation after total laryngectomy some acoustic parameters (fundamental frequency, waveform perturbation) were examined in 18 total laryngectomy patients. Eight of these subjects had previously been surgically rehabilitated with a tracheal-esophageal phonatory valve while 10 had been submitted to esophageal speech rehabilitation. Analysis of results has shown that tracheal-esophageal voices are more likely to provide a stable fundamental frequency; there is also a tendency toward more clearly defined harmonics; jitter and shimmer are more similar to the values of normal subjects compared with those observed in esophageal speech. Such results seem to depend on a more regular vibration pattern in the pharyngeal-esophageal segment, due to the more efficient expiratory flow in tracheal-esophageal speech. Moreover we were able to demonstrate a correlation between the objective parameters evaluated and the subjective score on speech acceptability.

Entities:  

Mesh:

Year:  1996        PMID: 8828283     DOI: 10.1159/000266416

Source DB:  PubMed          Journal:  Folia Phoniatr Logop        ISSN: 1021-7762            Impact factor:   0.849


  3 in total

1.  Intensity and fundamental frequency control in tracheoesophageal voice.

Authors:  A Schindler; A Canale; A L Cavalot; R Albera; P Capaccio; F Ottaviani; O Schindler
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-08       Impact factor: 2.124

2.  Voicing quantification is more relevant than period perturbation in substitution voices: an advanced acoustical study.

Authors:  P H Dejonckere; M B J Moerman; J P Martens; J Schoentgen; C Manfredi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-05       Impact factor: 2.503

3.  Objective evaluation of the quality of substitution voices.

Authors:  Mieke Moerman; Glenn Pieters; Jean-Pierre Martens; Marie-Jeanne Van der Borgt; Phillippe Dejonckere
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-01-15       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.